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Trainees frequently ask how mutations in a single gene can lead to different phenotypes. Most of us answer the question (with the requisite hand waving) by restating what we all learned in high school biology: Nonsense mutations resulting in stop codons produce a truncated gene product, and missense mutations result in altered protein function. Either type of mutation can result in a lack of normal protein function, thereby causing epilepsy. The real answer is probably more subtle and elegant. The more difficult question to answer is how different nonsense mutations in the same gene lead to different epilepsy syndromes. Many nonsense mutations lead to a process involving multimeric protein complexes, known as nonsense-mediated mRNA decay (1) . However, this is not always the case, particularly when mutations occur in exons near the end of the gene, as shown by Kang and coworkers in prior work (2) . In their latest publication, Kang and coworkers further unravel some of the complexity underlying this deceptively simple concept by examining mutations in the GABA A receptor γ 2 subunit (GABA A receptors typically consist of two α 1 , two β 2 and one γ 2 subunits) (3) . Mutations in the γ 2 subunit have been linked to syndromes across the spectrum of the epilepsies, from benign childhood absence epilepsy to the very serious Dravet syndrome (4) .
Regardless of the location of the nonsense mutation within the coding region (i.e., early or late exons, which ultimately code for the protein), the expression of γ 2 subunits on the surface of cultured cells is dramatically decreased, compared to wild-type γ 2 subunits. This raises two questions: Where did the partially translated products go? Do these truncated products adversely affect normal cellular function? To answer the first question, the authors used separate γ 2 "minigenes" (consisting of intron 8 and exon 9, the last exon) with three separate point mutations in exon 9 (epilepsy-linked Q390X, W429X and epilepsy-unrelated W461X; numbering in this study reflected the immature peptide, which includes an extra 39 amino acids) to measure mRNA and protein levels in cultured cells. mRNA levels were similar for all three constructs, but intracellular protein levels of Q390X were elevated above wildtype, whereas levels of W429X were decreased and levels of W461X were virtually undetectable. The rate of synthesis of W429X and Q390X were the same as wildtype, but protein degradation rates followed a pattern that was similar to protein levels (Q390X > wild type > W429X). When co-expressed with α 1 and β 2 subunits in cultured cells Trafficking-Deficient Mutant GABRG2 Subunit Amount May Modify Epilepsy Phenotype. Kang OBJECTIVE: Genetic epilepsies and many other human genetic diseases display phenotypic heterogeneity, often for unknown reasons. Disease severity associated with nonsense mutations is dependent partially on mutation gene location and resulting efficiency of nonsense-mediated mRNA decay (NMD) to eliminate potentially toxic proteins. Nonsense mutations in the last exon do not activate NMD, thus producing truncated proteins. We compared the protein metabolism and the impact on channel biogenesis, function, and cellular homeostasis of truncated γ2 subunits produced by GABRG2 nonsense mutations associated with epilepsy of different severities and by a nonsense mutation in the last exon unassociated with epilepsy. METHODS: γ-Aminobutyric acid type A receptor subunits were coexpressed in non-neuronal cells and neurons. NMD was studied using minigenes that support NMD. Protein degradation rates were determined using (35) S radiolabeling pulse chase. Channel function was determined by whole cell recordings, and subunits trafficking and cellular toxicity were determined using flow cytometry, immunoblotting, and immunohistochemistry. RESULTS: Although all GABRG2 nonsense mutations resulted in loss of γ2 subunit surface expression, the truncated subunits had different degradation rates and stabilities, suppression of wild-type subunit biogenesis and function, amounts of conjugation with polyubiquitin, and endoplasmic reticulum stress levels. INTERPRETATION: We compared molecular phenotypes of GABRG2 nonsense mutations. The findings suggest that despite the common loss of mutant allele function, each mutation produced different intracellular levels of trafficking-deficient subunits. The concentration-dependent suppression of wild-type channel function and cellular disturbance resulting from differences in mutant subunit metabolism may contribute to associated epilepsy severities and by implication to phenotypic heterogeneity in many inherited human diseases.
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(to more closely approximate the "native" receptor complex, rather than just an isolated protein), the mutant subunits were more sensitive to glycosidase digestion, consistent with their retention in the endoplasmic reticulum (because more mature glycosylation patterns are seen when proteins are transported to the Golgi apparatus). Q390X and W429X subunits both showed increased conjugation to polyubiquitin in cultured rat cortical neuron somata (which may lead to ubiquitin-proteasome degradation and synaptic dysfunction [5] ). To summarize, abnormal γ 2 gene products are located in the endoplasmic reticulum and may be more susceptible to degradation -both of which may lead to abnormal neuronal firing patterns.
What is the functional impact of these findings? When α 1 , β 2 , and truncated γ 2 subunits (Q390X and W429X) were expressed in cultured cells, there was a decrease in GABA A receptor currents. Aside from lack of function, could the truncated subunits be doing anything else harmful? In fact, expression of two of the truncated subunits (Q390X and W429X) led to reduced total levels of α 1 subunits, which could lead to abnormal neuronal firing. Further, there was a dose-dependent decrease in α 1 subunit expression with increasing relative amounts of γ 2 subunits. In a more clinically relevant model, total levels of α 1 subunit expression were decreased in Q390X mice engineered with the mutation but not GABRG2 knock-out mice, suggesting the loss of gene product alone was not the only deleterious factor. One potential mechanism is organelle dysfunction. Cultured cells expressing Q390X and W429X (but not W461X) showed increased expression of the growth arrest-and DNA damage-inducible gene 153 (GADD153), one marker of endoplasmic reticulum stress and the unfolded protein response (UPR), which in turn can lead to cellular dysfunction and diversion of intracellular resources from their typical constitutive processes (7) . Low levels of cell death were noted in Q390X-transfected cells but not with the other constructs. So, where does this leave our understanding of the different mutations and their corresponding phenotypes? The focus of this work was cultured HEK293T cells, cultured rat cortical neurons, and L929 cells. These data represent an important first step in defining which questions can be asked regarding intact animals, in the presence of the full circuitry of functional neurons, glia, and other cells. Are there pathological compensatory effects in other neurotransmitter receptor subunits (either GABA A , glutamate, or other channels) in response to mutations in the final exons of GABRG2? Is there evidence of cell death as a result of ER stress (including the UPR); if so, are certain cell populations (i.e., interneurons) more vulnerable than others? GADD153 has not been implicated directly in neuronal dysfunction in epilepsy but is this yet another avenue to explore? As the authors note, the amino acids missing from the Q390X mutant but present in the W429X mutant include charged residues, palmitoylation sites, tyrosine phosphorylation sites, and a GABARAP (GABA receptor binding protein) binding site. What contribution is made by each of these factors to the ultimate phenotype? GABARAP also plays a role in the later stages of macroautophagy, suggesting that there may be additional pathways of cellular dysfunction to investigate using the truncated γ 2 subunits (8) . Finally, findings similar to those noted by Kang and coworkers were recently reported with mutations in the second exon (Q40X), raising the question of how specific many of these cellular changes are for mutations in the final exon (9) .
In summary, different nonsense mutations in γ 2 subunits have very different profiles of biochemical and functional abnormalities (Table 1 ). There are many similarities in functional outcomes (e.g., effect on α 1 subunit expression, peak current amplitudes, and zinc sensitivity), although the relative levels of each may reflect subtle differences in protein stability and trafficking. The gradient of changes seen in some assays also correlates with the location of the mutation, which at some level also may reflect their structural characteristics in neuronal membranes. Despite the advances in our understanding of the genetics of epilepsy, it is clear that many questions of cell biological nature remain to be clarified.
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